Install
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
- 913articles · 365d
- 2+ hour agolatest article
- Sep 14, 2025earliest in window
- 95%with images
- 285avg words
- Medical 573
- Business & Industrial 538
- Economy, Business & Finance 451
- Health & Wellness 337
- Health 267
- Finance & Business 254
- Science & Technology 156
- Science & Nature 42
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Boards, AI, and 500 Years of Experience in Life Sciences: Takeaways from the 2026 Life Sciences Board Forum
2+ hour, 7+ min ago (92+ words) This June, ten of the life sciences industry’s most respected board members came to New York for Accenture’s second annual Life Sciences Board Forum for something this industr... Ten life sciences board directors on AI's three hardest questions: developing the…...
Zeno???s Paradox, Orphan Product Access and the Future of Unmet Need
2+ day, 2+ hour ago (364+ words) Unmet need is likely a new battlefield impacting prior authorization. CMS ACCESS Model: Changing the Landscape of Disease Management Orphan Product Risk Contracting Future Phase III Trial Planning: Payer Point of View Zeno’s paradox is a riddle about motion and…...
The Agentic AI Revolution in Biopharma
2+ day, 2+ hour ago (1556+ words) How agentic artificial intelligence is transforming the value chain from discovery to commercialization. The biopharmaceutical industry is undergoing a profound transformation, driven by the emergence of agentic artificial intelligence (AI). Unlike traditional AI models that require continuous human guidance, agentic…...
How ClaimGuardRx's Purpose-Built AI Detects and Counters Diversion Tactics
3+ day, 11+ hour ago (124+ words) Pharmaceutical Executive Sponsored by Paysign Bryan Dennison, Senior Vice President of Sales and Product at Paysign, explains the technical foundation of ClaimGuardRx, a proprietary large language model (LLM) trained specifically on patient affordability claim patterns rather than adapted from a general-purpose…...
Unlocking the Future of Real-World Data & Research | PharmExec
3+ day, 14+ hour ago (40+ words) Unlocking the Future of Real-World Data & Research Pharmaceutical Executive Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B Trusted Research Environments Are Reshaping Real-World Data Access: Q&A with Mark Cziraky FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults...
Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B
4+ day, 35+ min ago (83+ words) Moonwalk Biosciences' $70 Million Series B | PharmExec Pharmaceutical Executive Aptar Pharma and Aceso Therapeutics team up to advance an inhaled cystic fibrosis therapy, Moonwalk Biosciences raises a $70 million Series B for its fat-targeted obesity platform, and Sebastian Arana of MilliporeSigma talks…...
Trusted Research Environments Are Reshaping Real-World Data Access: Q&A with Mark Cziraky
5+ day, 14+ hour ago (497+ words) Pharmaceutical Executive The pharma and biotech industries run on data, especially on the R&D side Data is one of the most valuable assets, but it can also cause some of the biggest headaches Due to the wide array of…...
Exploring the Real Reasons Why RBQM Implementation Fails
1+ week, 4+ day ago (78+ words) Pharmaceutical Executive RBQM implementations fail not because the software is wrong — but because the human environment surrounding it was never engineered. There is a myth in our industry that when an RBQM implementation fails to deliver the cause must be…...
Why AI Trust Comes Down to One Equation: Q&A with Parth Khanna
1+ week, 4+ day ago (400+ words) ACTO’s CEO on AI trust, the future of the sales rep, and why human intelligence plus empathetic agents is the winning formula. Over recent years, the pharmaceutical industry has generally embraced AI. Due the nature of the technology, various companies…...
The Industry???s Shift on RWD
1+ week, 4+ day ago (247+ words) Carelon Research's Mark Cziraky on why the industry's need for deeper, linked data is driving a shift toward trusted research environments. The pharma and biotech industries run on data, especially on the R&D side. Data is one of the…...